We are 4-Cloromethyl-5-methyl-1,3-dioxol-2-one CAS:80841-78-7 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 4-Cloromethyl-5-methyl-1,3-dioxol-2-one
T5OVOJ D1G E1
Molecular Formula: C5H5ClO3
Physical and Chemical Properties:
Density: 1.362 g / cm3
Boiling point: 163.2ºC at 760 mmHg
Flash point: 66.7ºC
Refractive index: 1.481
Appearance:Yellow liquid or yellow-brown liquid
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Olmesartan medoxomil CAS:144689-63-4
Intermediates of Olmesartan CAS:144689-24-7
Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.(S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid CAS:868540-16-3 Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”2-methyloxolan-3-one Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”27821-45-0 Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.